Speakers

Mark Albertella

Vice President, Translational Oncology

Storm Therapeutics

Mahesh Karande

President and CEO

Omega Therapeutics

Robert Yauch

Director & Principal Scientist, Discovery Oncology

Genentech

Hugh Young

Reinhoff, CEO

Imago BioSciences

Stephen Baylin

Professor of Oncology

John Hopkins University

Svetlana Hamm

Head of Research and Translational Medicine

4SC

Paul Kayne

Former Head, Discovery Genomics & Proteomics

Bristol-Myers Squibb

Antonello Mai

Professor

Spienza University of Rome

Neil Michaud

Senior Director, Translational Medicine

Epizyme

Peter Atadja

Director & Head, Drug Discovery

Novartis

Norman Wong

Co-Founder and CSO

Resverlogix Corp

Susan Wee

Senior Director, Oncology Drug Discovery

Incyte

Eric Campeau

Senior Director, Translational Medicine

Zenith Epigenetics

Robert Copeland

President, Chief Scientific Officer and Co-Founder

Accent Therapeutics

Robert Brown

Professor

Imperial College London

Kai He

Assistant Professor of Medicine The Ohio State

University College of Medicine

Rajarshi Choudhury

Genome Editing Investigator

GSK

Tamara Maes

CSO, VP and founder

Oryzon Genomics

Robert Soliva

Drug Discovery Director

Oryzon Genomics

Elisabetta Chiarparin

Director of Oncology Chemistry and Programme Leader

AstraZeneca

Richard Trauger

Senior Director Translational Medicine

Viracta Therapeutics

Alon Goren

Assistant Professor, Department of Medicine

University of California San Diego